- Conditions
- Persian Gulf Syndrome
- Interventions
- Carnosine, Placebo
- Drug
- Lead sponsor
- Georgetown University
- Other
- Eligibility
- 34 Years to 82 Years
- Enrollment
- 33 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2012
- U.S. locations
- 1
- States / cities
- Washington D.C., District of Columbia
Search Results
Search by objective public record fields.
Search by query text, NCT ID, condition, intervention, sponsor, city, state, recruitment status, phase, study type, healthy volunteer eligibility, sex, or age. Results come from ClinicalTrials.gov. When the live registry is unavailable, a clearly labeled stored copy may be shown.
These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Showing 313–319
of 319
matching trials from the live ClinicalTrials.gov search.
- Conditions
- Glucose, Circadian Rhythm, Melatonin, Genes, Light
- Interventions
- placebo, melatonin, bright light, dim light
- Drug · Dietary Supplement · Other
- Lead sponsor
- Brigham and Women's Hospital
- Other
- Eligibility
- 21 Years to 55 Years
- Enrollment
- 24 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2022
- U.S. locations
- 1
- States / cities
- Boston, Massachusetts
- Conditions
- Progressive Supranuclear Palsy(PSP), Insomnia
- Interventions
- Suvorexant, Zolpidem, Placebo oral capsule
- Drug
- Lead sponsor
- University of California, San Francisco
- Other
- Eligibility
- 18 Years and older
- Enrollment
- 40 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2019 – 2025
- U.S. locations
- 1
- States / cities
- San Francisco, California
- Conditions
- Systemic Lupus Erythematosus, SLE, Lupus
- Interventions
- Vitamin D3, Vitamin D3 placebo
- Drug
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- NIH
- Eligibility
- 18 Years and older
- Enrollment
- 57 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2008 – 2011
- U.S. locations
- 8
- States / cities
- Birmingham, Alabama • San Francisco, California • Boston, Massachusetts + 5 more
- Conditions
- Fatty Liver
- Interventions
- Group 1 NRPT, Group 2 NRPT, Group 3 Placebo
- Dietary Supplement · Other
- Lead sponsor
- Elysium Health
- Industry
- Eligibility
- 18 Years to 70 Years
- Enrollment
- 111 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2018 – 2020
- U.S. locations
- 9
- States / cities
- Hialeah, Florida • Lake Worth, Florida • Miami, Florida + 5 more
- Conditions
- Intestinal Permeability
- Interventions
- plant derived phenolics, Microcrystaline cellulose (MCC)
- Dietary Supplement · Other
- Lead sponsor
- Brightseed
- Industry
- Eligibility
- 30 Years to 69 Years
- Enrollment
- 126 participants
- Healthy volunteers
- Accepts healthy volunteers
- Timeline
- 2024 – 2025
- U.S. locations
- 1
- States / cities
- Addison, Illinois
- Conditions
- Alcohol Use Disorder
- Interventions
- Placebo, Glucagon-Like Peptide-1 Agonist (GLP-1), Naltrexone (oral tablets)
- Drug
- Lead sponsor
- Johns Hopkins University
- Other
- Eligibility
- 21 Years to 65 Years
- Enrollment
- 45 participants
- Healthy volunteers
- Healthy volunteers not accepted
- Timeline
- 2026 – 2028
- U.S. locations
- 1
- States / cities
- Havre de Grace, Maryland